MX357061B - Diseño de inmunogenos a base de linaje de celulas b con animales humanizados. - Google Patents
Diseño de inmunogenos a base de linaje de celulas b con animales humanizados.Info
- Publication number
- MX357061B MX357061B MX2015010110A MX2015010110A MX357061B MX 357061 B MX357061 B MX 357061B MX 2015010110 A MX2015010110 A MX 2015010110A MX 2015010110 A MX2015010110 A MX 2015010110A MX 357061 B MX357061 B MX 357061B
- Authority
- MX
- Mexico
- Prior art keywords
- design
- cell lineage
- methods
- immunogen design
- humanized animals
- Prior art date
Links
- 241001465754 Metazoa Species 0.000 title abstract 3
- 230000002163 immunogen Effects 0.000 title abstract 2
- 210000003719 b-lymphocyte Anatomy 0.000 title 1
- 238000000034 method Methods 0.000 abstract 3
- 108060003951 Immunoglobulin Proteins 0.000 abstract 2
- 102000018358 immunoglobulin Human genes 0.000 abstract 2
- 229960005486 vaccine Drugs 0.000 abstract 2
- 239000012678 infectious agent Substances 0.000 abstract 1
- 230000003472 neutralizing effect Effects 0.000 abstract 1
- 244000052769 pathogen Species 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
- A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1018—Orthomyxoviridae, e.g. influenza virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1036—Retroviridae, e.g. leukemia viruses
- C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/07—Animals genetically altered by homologous recombination
- A01K2217/072—Animals genetically altered by homologous recombination maintaining or altering function, i.e. knock in
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/105—Murine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/01—Animal expressing industrially exogenous proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Environmental Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Animal Husbandry (AREA)
- Engineering & Computer Science (AREA)
- Biodiversity & Conservation Biology (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Communicable Diseases (AREA)
- AIDS & HIV (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
Abstract
La presente invención se refiere a animales no humanos con loci de inmunoglobulina humanizados y métodos para usarlos en el diseño de vacunas, y también se proporcionan métodos para hacer anticuerpos de amplia neutralización contra agentes infecciosos y patógenos. Se proporcionan animales no humanos con loci de inmunoglobulina humanizados usados en el diseño de inmunógenos de linaje de células B en el desarrollo de vacunas, así como métodos para llevar a cabo tal diseño.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361761419P | 2013-02-06 | 2013-02-06 | |
PCT/US2014/015133 WO2014124156A1 (en) | 2013-02-06 | 2014-02-06 | B cell lineage based immunogen design with humanized animals |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2015010110A MX2015010110A (es) | 2016-06-21 |
MX357061B true MX357061B (es) | 2018-06-25 |
Family
ID=50150835
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2015010110A MX357061B (es) | 2013-02-06 | 2014-02-06 | Diseño de inmunogenos a base de linaje de celulas b con animales humanizados. |
Country Status (12)
Country | Link |
---|---|
US (2) | US9963501B2 (es) |
EP (1) | EP2953452A1 (es) |
KR (1) | KR20150115775A (es) |
AU (2) | AU2014214863B2 (es) |
CA (1) | CA2899740A1 (es) |
HK (1) | HK1218866A1 (es) |
IL (1) | IL240114B (es) |
MX (1) | MX357061B (es) |
RU (1) | RU2664187C2 (es) |
SG (2) | SG11201505713YA (es) |
WO (1) | WO2014124156A1 (es) |
ZA (1) | ZA201505307B (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2012279018B2 (en) | 2011-07-05 | 2017-06-08 | Children's Medical Center Corporation | N-terminal deleted GP120 immunogens |
WO2013052095A2 (en) | 2011-10-03 | 2013-04-11 | Duke University | Vaccine |
EP2953452A1 (en) | 2013-02-06 | 2015-12-16 | Regeneron Pharmaceuticals, Inc. | B cell lineage based immunogen design with humanized animals |
AU2017221425A1 (en) * | 2016-02-16 | 2018-08-23 | Regeneron Pharmaceuticals, Inc. | Non-human animals having a mutant kynureninase gene |
CA3125380A1 (en) | 2019-02-18 | 2020-08-27 | Biocytogen Pharmaceuticals (Beijing) Co., Ltd. | Genetically modified non-human animals with humanized immunoglobulin locus |
EP4158034A4 (en) | 2020-06-02 | 2024-07-03 | Biocytogen Pharmaceuticals Beijing Co Ltd | GENETICALLY MODIFIED NON-HUMAN ANIMALS HAVING A LIGHT-CHAIN IMMUNOGLOBULIN LOCUS |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2322108A (en) | 1939-04-21 | 1943-06-15 | Molins Machine Co Ltd | Weighing apparatus |
US5770429A (en) * | 1990-08-29 | 1998-06-23 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
US6596541B2 (en) | 2000-10-31 | 2003-07-22 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
US7105348B2 (en) | 2000-10-31 | 2006-09-12 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
JP4720065B2 (ja) | 2001-09-04 | 2011-07-13 | 日本電気株式会社 | フィルム外装電池及び組電池 |
CN102638971B (zh) | 2009-07-08 | 2015-10-07 | 科马布有限公司 | 动物模型及治疗分子 |
PL2578688T5 (pl) | 2011-02-25 | 2023-05-29 | Regeneron Pharmaceuticals, Inc. | Myszy adam6 |
WO2013052095A2 (en) | 2011-10-03 | 2013-04-11 | Duke University | Vaccine |
EP2953452A1 (en) | 2013-02-06 | 2015-12-16 | Regeneron Pharmaceuticals, Inc. | B cell lineage based immunogen design with humanized animals |
-
2014
- 2014-02-06 EP EP14705679.0A patent/EP2953452A1/en not_active Ceased
- 2014-02-06 MX MX2015010110A patent/MX357061B/es active IP Right Grant
- 2014-02-06 KR KR1020157021156A patent/KR20150115775A/ko not_active Application Discontinuation
- 2014-02-06 RU RU2015137173A patent/RU2664187C2/ru not_active IP Right Cessation
- 2014-02-06 US US14/174,563 patent/US9963501B2/en active Active
- 2014-02-06 WO PCT/US2014/015133 patent/WO2014124156A1/en active Application Filing
- 2014-02-06 SG SG11201505713YA patent/SG11201505713YA/en unknown
- 2014-02-06 CA CA2899740A patent/CA2899740A1/en not_active Abandoned
- 2014-02-06 AU AU2014214863A patent/AU2014214863B2/en not_active Ceased
- 2014-02-06 SG SG10201706190PA patent/SG10201706190PA/en unknown
-
2015
- 2015-07-22 ZA ZA2015/05307A patent/ZA201505307B/en unknown
- 2015-07-23 IL IL240114A patent/IL240114B/en not_active IP Right Cessation
-
2016
- 2016-06-15 HK HK16106896.4A patent/HK1218866A1/zh unknown
-
2018
- 2018-03-29 US US15/940,523 patent/US10626168B2/en active Active
-
2019
- 2019-06-20 AU AU2019204329A patent/AU2019204329A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2899740A1 (en) | 2014-08-14 |
AU2014214863B2 (en) | 2019-03-21 |
MX2015010110A (es) | 2016-06-21 |
US20180298082A1 (en) | 2018-10-18 |
SG10201706190PA (en) | 2017-09-28 |
KR20150115775A (ko) | 2015-10-14 |
US9963501B2 (en) | 2018-05-08 |
US10626168B2 (en) | 2020-04-21 |
SG11201505713YA (en) | 2015-08-28 |
AU2014214863A1 (en) | 2015-09-24 |
EP2953452A1 (en) | 2015-12-16 |
AU2019204329A1 (en) | 2019-07-11 |
ZA201505307B (en) | 2016-07-27 |
RU2015137173A (ru) | 2017-03-13 |
HK1218866A1 (zh) | 2017-03-17 |
US20140221625A1 (en) | 2014-08-07 |
IL240114A0 (en) | 2015-09-24 |
IL240114B (en) | 2019-08-29 |
WO2014124156A1 (en) | 2014-08-14 |
RU2664187C2 (ru) | 2018-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2018001141A1 (es) | Anticuerpo que neutraliza el virus respiratorio sincitial humano. | |
HK1248251A1 (zh) | 用於flt3和cd3的抗體構建體 | |
CL2017000711A1 (es) | Diacuerpos monovalentes biespecíficos que son capaces de unir cd19 y cd3, y usos de los mismos. | |
MX2015010110A (es) | Diseño de inmunogenos a base de linaje de celulas b con animales humanizados. | |
PH12015501954A1 (en) | Anti-b7-h4 antibodies and immunoconjugates | |
PH12015502293A1 (en) | Bispecific antibodies specific for fap and dr5, antibodies specific for dr5 and methods of use | |
ES2980493T3 (es) | Métodos de recolección en cultivos de células de mamífero | |
CU20170074A7 (es) | Anticuerpos heterodiméricos que se unen a cd3 y a antígenos tumorales | |
AR101845A1 (es) | Anticuerpos anti-her2 e inmunoconjugados | |
TN2017000246A1 (en) | Anti-c10orf54 antibodies and uses thereof | |
MX2017008819A (es) | Anticuerpos anti-cd47 y usos de los mismos. | |
MX2017006802A (es) | Animales no humanos que expresan el complejo cd3 humanizado. | |
EA201590993A1 (ru) | Гетеродимерные иммуноглобулины | |
MX2016007576A (es) | Anticuerpos e inmunoconjugados anti-cd33. | |
EA201400875A1 (ru) | Антитела к cd47 и способы их применения | |
MX2019015604A (es) | Anticuerpos anti-tau y usos de los mismos en el tratamiento de una tauopatia. | |
IL241433A0 (en) | A protocol for identifying and isolating antigens specific to b cells and creating antibodies to desired antigens | |
BR112018003526A2 (pt) | métodos de tratamento de doenças inflamatórias | |
MX2016004802A (es) | Anticuerpos anti-r-espondina (anti-rspo) y metodos de uso. | |
MY175418A (en) | Compositions comprising anti-cd38 antibodies and carfilzomib | |
IL245190A0 (en) | Preparation of antibodies from cho cell cultures for conjugation | |
NZ710744A (en) | Methods for increasing immunoglobulin a levels | |
EA201691502A1 (ru) | Мутантные стафилококковые антигены | |
MX2016005854A (es) | Anticuerpo anti-her3 alosterico de la neuregulina. | |
IL261802A (en) | Neutralizing monoclonal antibodies to IL-25 and their use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |